Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Other 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 5Neoplasms 3Uterine Neoplasms 1Stomach Neoplasms 1Obesity 1Motor Activity 1Colorectal Neoplasms 1Cholangiocarcinoma 1Cardiotoxicity 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Neoplasms × Biomarkers × Clear all
NCT01870947 2020-01-27

Assisted Exercise in Obese Endometrial Cancer Patients

Case Comprehensive Cancer Center

Phase NA Completed
95 enrolled
GynecologicOther

Motor Activity, Neoplasms, Obesity, Uterine Neoplasms

NCT00984035 2018-09-11

Investigation of Cisplatin-Related Kidney Toxicity

University of Chicago

Completed
102 enrolled
Tumor-Agnostic

Neoplasms

NCT00539422 2007-10-04

Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases

Mansoura University

Completed
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡